Clinical Trials Browser

NCT07117630 2026-05-19

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Phase 2 Recruiting

40 enrolled

Breast

Breast Neoplasms

NCT04481035 2026-04-21

NF1NAC

Phase 2 Completed

5 enrolled 10 charts

CNS

Neurofibromatosis 1

NCT05986318 2026-03-09

RESPIRE-ILD

Phase 2 Recruiting

98 enrolled

Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT07245095 2025-11-24

NACSIMET

Phase 2 Recruiting

132 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02569957 2025-05-04

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Terminated

1 enrolled 5 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06354712 2025-01-15

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Phase 2 Recruiting

50 enrolled

Stomatitis, Ulcer

NCT06482034 2024-12-31

Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis

Phase 2 Completed

50 enrolled

Other

Radiation-Induced Mucositis

NCT06024031 2024-11-07

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

Phase 2 Active not recruiting

30 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04481048 2024-10-09

DoDNAC

Phase 2 Active not recruiting

58 enrolled

CNS

Neurofibromatosis 1

NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Phase 2 Unknown

60 enrolled

Ototoxicity, Peripheral Nervous System Diseases

NCT03982537 2022-12-19

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Phase 2 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Phase 2 Unknown

62 enrolled

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

NCT02123511 2019-04-30

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Phase 2 Completed

34 enrolled 16 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms, Mucositis

NCT01726465 2013-11-13

MENHIR

Phase 2 Terminated

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

80 enrolled

Dermatologic

Melanoma

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Phase 2 Completed

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

60 enrolled

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss